Evidence map›Paper›PMID 40011510›Full record

ArticleScientific reports2025

A labeled medical records corpus for the timely detection of rare diseases using machine learning approaches.

Matias Rolando, Victor Raggio, Hugo Naya, Lucia Spangenberg, Leticia Cagnina

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Matias RolandoBioinformatics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Victor RaggioDepartamento de Genética, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
Hugo NayaBioinformatics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Lucia SpangenbergBioinformatics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay. lucia@pasteur.edu.uy.
Leticia CagninaUniversidad Nacional de San Luis, San Luis, Argentina. lcagnina@unsl.edu.ar.

Funding

Consejo Nacional de Investigaciones Científicas y Técnicas Short Research StagesINNOVA II DCI‑ALA /2011/23‑502Inter-American Development Bank Proyecto ATN/KK-L4584-"Fortalecimiento de las capacidades técnicas y humanas para las exportaciones de servicios genómicos"
6 · The paper itself

Abstract

Rare diseases (RDs) are a group of pathologies that individually affect less than 1 in 2000 people but collectively impact around 7% of the world's population. Most of them affect children, are chronic and progressive, and have no specific treatment. RD patients face diagnostic challenges, with an average diagnosis time of 5 years, multiple specialist visits, and invasive procedures. This 'diagnostic odyssey' can be detrimental to their health. Machine learning (ML) has the potential to improve healthcare by providing more personalized and accurate patient management, diagnoses, and in some cases, treatments. Leveraging the MIMIC-III database and additional medical notes from different sources such as in-house data, PubMed and chatGPT, we propose a labeled dataset for early RD detection in hospital settings. Applying various supervised ML methods, including logistic regression, decision trees, support vector machine (SVM), deep learning methods (LSTM and CNN), and Transformers (BERT), we validated the use of the proposed resource, achieving 92.7% F-measure and a 96% AUC using SVM. These findings highlight the potential of ML in redirecting RD patients towards more accurate diagnostic pathways and presents a corpus that can be used for future development and refinements.

Indexed as

Machine LearningMedical RecordsRare DiseasesDeep LearningHumansSupport Vector Machine

Identifiers

PMID40011510
PMCPMC11865299

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.